Funding

Respiro Diagnostics

United Kingdom · Healthtech · Biotech

Develops breath-based diagnostic platform for lung cancer and respiratory diseases

Visit respirodiagnostics.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Pre-Seed£1MAmadeus Capital Partners — Role not disclosedConception X Angel Syndicate — Role not disclosedFrancis Crick Institute — Role not disclosedInnovate UK — Role not disclosedKQ Labs — Role not disclosedSFC Capital — Role not disclosedZinc Venture Capital — Role not disclosed

Investors

Amadeus Capital PartnersPre-SeedConception X Angel SyndicatePre-SeedFrancis Crick InstitutePre-SeedInnovate UKPre-SeedKQ LabsPre-SeedSFC CapitalPre-SeedZinc Venture CapitalPre-Seed

Coverage

Jul 8, 2026Respiro Diagnostics · Pre-Seed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesrespirodiagnostics.com ↗